Primary Care

Behavioral Neurology & Neuropsychiatry

Questions discussed in this category

Is there an age cutoff where you consider the risks of monoclonal antibody therapy outweigh any potential benefit(s) in early-onset dementia?

1 Answer available

How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?

2 Answers available

How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?

4 Answers available

When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?

1 Answer available

How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?

2 Answers available

How do you implement antipsychotics in the management of agitation in Alzheimer’s patients?

3 Answers available

How do you manage antipsychotic-induced prolactinemia?

1 Answer available

What is the best treatment for treatment resistant restless leg syndrome?

2 Answers available

What are preferred sleep aids in elderly patients with dementia?

6 Answers available

Is a history of coronary artery disease and afib a contraindication to using donepezil?

How do you counsel patients about any potential risk?

1 Answer available

How will your approach to screening and diagnosis of early dementia change given newly available therapies for early Alzheimer's disease?

5 Answers available

In what clinical situation would you consider using benzodiazepines in patients with dementia?

2 Answers available

Do you use acetylcholinesterase inhibitors in patients with cognitive changes in the setting of cerebral amyloid angiopathy?

1 Answer available

When do you consider prescribing medications such as Aricept in patients with Down Syndrome who start having memory issues?

2 Answers available

When do you recommend driving tests in patients who have memory loss?

1 Answer available

How do you manage the developmental and behavioral regression seen in Down Syndrome Disintegrative Disorder (DSDD)?

1 Answer available

How do you treat behavioral disturbances in patients with dementia with Lewy bodies?

How do you treat dangerous behavioral disturbances (aggression, nighttime wandering) in patients with dementia with Lewy bodies (DLB)?

2 Answers available

For patients with significant side effects to a cholinesterase inhibitor, do you try another medication in the class or avoid it altogether?

If you have significant side effects, GI and/or cardiac with one of the cholinesterase inhibitors, would you try using another medication or would you...

1 Answer available

Papers discussed in this category

Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022 Aug 15

The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.

The journal of prevention of Alzheimer's disease, 2022

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.

The American journal of psychiatry, 2022 Aug

Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management.

Psychiatry research, 2020 Dec 13

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.

Journal of psychopharmacology (Oxford, England), 2018 Jan 17

Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.

The journal of prevention of Alzheimer's disease, 2023

Lecanemab: Appropriate Use Recommendations.

Stroke, 2024 Dec 11

Vascular Neurology Considerations for Antiamyloid Immunotherapy: A Science Advisory From the American Heart Association.

Lancet (London, England), 2015 Mar 12

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

Related Topics in Primary Care